CALX.NYSECalix, INC

Form 4: Calix Director Rajatish Mukherjee Acquires Stock Options

Sentiment:

SEC Form 4 Filing


Director Rajatish Mukherjee acquired 12,262 stock options in Calix, Inc. on May 9, 2024.

Summary

  • On May 9, 2024, Rajatish Mukherjee, a director of Calix, Inc., acquired 12,262 stock options.
  • The exercise price of these options is $30.07.
  • The options vest and become exercisable on the earlier of May 9, 2025, or the day before the next annual meeting of stockholders.
  • The options expire on May 9, 2034.
  • Following the transaction, Mukherjee directly owns 12,262 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock option grants to a director. While option grants can be seen as a positive incentive, the filing itself doesn't provide strong positive or negative signals.

Positives

  • The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders, such as directors and officers, trade in their company's stock. This filing indicates a grant of stock options to a director, which is a common form of executive compensation.

Stakeholder Impact

  • The grant of stock options aligns the director's interests with those of the shareholders, incentivizing them to increase the company's value.

Key Dates

DateDescription
05/09/2024Date of transaction: Rajatish Mukherjee acquired stock options.
05/09/2024Date of grant of stock options.
05/09/2034Expiration date of the stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.